Page 7 - pitch Merylo
P. 7
STRATEGY
1 ST TARGET PATHOLOGY: ORPHAN DISEASE SMALL CHEMIOTHERAPIC MOLECULE
(speed up validation)
SMALL CHEMOTHERAPIC MOLECULE
2 ND TARGET PATHOLOGY MONOCLONAL ANTIBODY
(increase market share)
PROTEINS, NANOPARTICLES, RNA, PEPTIDES...
